A Study to Evaluate the Safety and Effectiveness of a Silicone Hydrogel Custom Contact Lens When Compared to Alden Optical HP Sphere Lens
Public ClinicalTrials.gov record NCT03897712. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Evaluate the Safety and Effectiveness of a Silicone Hydrogel Custom Contact Lens
Study identification
- NCT ID
- NCT03897712
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Bausch & Lomb Incorporated
- Industry
- Enrollment
- 84 participants
Conditions and interventions
Conditions
Interventions
- Custom Samfilcon B Contact Lenses Device
- Alden Optical HP Sphere Contact Lens Device
- ReNu MultiPlus Lubricating and Rewetting Drops Device
- Biotrue Multi-Purpose Solution Device
Device
Eligibility (public fields only)
- Age range
- 18 Years to 40 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 26, 2019
- Primary completion
- Aug 27, 2019
- Completion
- Aug 27, 2019
- Last update posted
- Nov 13, 2022
2019
United States locations
- U.S. sites
- 7
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Bausch Site 1 | San Francisco | California | 94112 | — |
| Bausch Site 2 | Denver | Colorado | 80246 | — |
| Bausch Site 3 | Sarasota | Florida | 34232 | — |
| Bausch Site 4 | Pittsburg | Kansas | 66762 | — |
| Bausch Site 5 | Warrensburg | Missouri | 64093 | — |
| Bausch Site 6 | Vestal | New York | 13850 | — |
| Bausch Site 7 | New Berlin | Wisconsin | 53151 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03897712, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 13, 2022 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03897712 live on ClinicalTrials.gov.